Skip to main content
Erschienen in:

10.01.2022 | Gastrointestinal Oncology

Propensity Score-Matched Analysis of the Short- and Long-Term Outcomes of Robotic Versus Laparoscopic Gastrectomy for Gastric Cancer

verfasst von: Masaaki Nishi, MD, PhD, FACS, Mistuo Shimada, MD, Kozo Yoshikawa, MD, Chie Takasu, MD, Yuma Wada, MD, Takuya Tokunaga, MD, Toshihiro Nakao, MD, Hideya Kashihara, MD, Toshiaki Yoshimoto, MD, Shoko Yamashita, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 6/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

Robotic gastrectomy (RG) has been rapidly adopted for gastric cancer (GC) treatment. However, the benefits of RG over laparoscopic gastrectomy (LG) for GC remain unclear.

Methods

A total of 451 patients who underwent either RG (n = 83) or LG (n = 368) for GC were enrolled in this study. A 1:1 matched, propensity score-matched analysis was performed using the following factors: age, sex, body mass index, pT, pN, pStage, tumor location, vessel invasion, tumor markers, surgical procedure, reconstruction method, extent of lymphadenectomy, and Endoscopic Surgical Skill Qualification System qualified surgeon as an operator. The surgical outcomes of the two groups were compared.

Results

A well-balanced cohort of 158 patients was analyzed (n = 79 in the RG group, n = 79 in the LG group). Regarding the short-term outcomes, the respective blood loss volume, drain amylase content, and number of retrieved lymph nodes in the RG and LG groups were 38.62 ± 73.06 ml and 67.53 ± 108.20 ml (p < 0.05), 450 ± 371 IU/l and 1590 ± 6392 IU/l (p < 0.01), and 35.02 ± 15.51 and 25.28 ± 11.70 (p < 0.01). The morbidity rate was similar between the RG and LG groups (not significant [NS]). Regarding the long-term survival outcomes, there were no intergroup differences in 3-year overall survival (91.72% in the RG group vs. 83.39% in the LG group: NS) and 3-year, disease-free survival (93.31% in the vs. 90.44%: NS).

Conclusions

RG was safe and contributed to better short-term outcomes and similar long-term survival outcomes compared with LG.
Literatur
1.
Zurück zum Zitat Terashima M. The 140 years’ journey of gastric cancer surgery: from the two hands of Billroth to the multiple hands of the robot. Ann Gastroenterol Surg. 2021;5(3):270–7.CrossRef Terashima M. The 140 years’ journey of gastric cancer surgery: from the two hands of Billroth to the multiple hands of the robot. Ann Gastroenterol Surg. 2021;5(3):270–7.CrossRef
2.
Zurück zum Zitat Kinoshita T, Uyama I, Terashima M, et al. LOC-A Study Group. Long-term outcomes of laparoscopic versus open surgery for clinical stage II/III gastric cancer: a multicenter cohort study in Japan (LOC-A study). Ann Surg. 2019;269(5):887-94. Kinoshita T, Uyama I, Terashima M, et al. LOC-A Study Group. Long-term outcomes of laparoscopic versus open surgery for clinical stage II/III gastric cancer: a multicenter cohort study in Japan (LOC-A study). Ann Surg. 2019;269(5):887-94.
3.
Zurück zum Zitat Katai H, Mizusawa J, Katayama H, et al. Survival outcomes after laparoscopy-assisted distal gastrectomy versus open distal gastrectomy with nodal dissection for clinical stage IA or IB gastric cancer (JCOG0912): a multicentre, non-inferiority, phase 3 randomised controlled trial. Lancet Gastroenterol Hepatol. 2020;5(2):142–51.CrossRef Katai H, Mizusawa J, Katayama H, et al. Survival outcomes after laparoscopy-assisted distal gastrectomy versus open distal gastrectomy with nodal dissection for clinical stage IA or IB gastric cancer (JCOG0912): a multicentre, non-inferiority, phase 3 randomised controlled trial. Lancet Gastroenterol Hepatol. 2020;5(2):142–51.CrossRef
4.
Zurück zum Zitat Lee HJ, Hyung WJ, Yang HK, et al. Korean Laparo-endoscopic Gastrointestinal Surgery Study (KLASS) Group. Short-term outcomes of a multicenter randomized controlled trial comparing laparoscopic distal gastrectomy with D2 lymphadenectomy to open distal gastrectomy for locally advanced gastric cancer (KLASS-02-RCT). Ann Surg. 2019;270(6):983-91. Lee HJ, Hyung WJ, Yang HK, et al. Korean Laparo-endoscopic Gastrointestinal Surgery Study (KLASS) Group. Short-term outcomes of a multicenter randomized controlled trial comparing laparoscopic distal gastrectomy with D2 lymphadenectomy to open distal gastrectomy for locally advanced gastric cancer (KLASS-02-RCT). Ann Surg. 2019;270(6):983-91.
5.
Zurück zum Zitat Kim HH, Han SU, Kim MC, et al. Korean Laparoendoscopic Gastrointestinal Surgery Study (KLASS) Group. Effect of laparoscopic distal gastrectomy vs open distal gastrectomy on long-term survival among patients with Stage I gastric cancer: The KLASS-01 Randomized Clinical Trial. JAMA Oncol. 2019;5(4):506-13. Kim HH, Han SU, Kim MC, et al. Korean Laparoendoscopic Gastrointestinal Surgery Study (KLASS) Group. Effect of laparoscopic distal gastrectomy vs open distal gastrectomy on long-term survival among patients with Stage I gastric cancer: The KLASS-01 Randomized Clinical Trial. JAMA Oncol. 2019;5(4):506-13.
6.
Zurück zum Zitat Kitano S, Iso Y, Moriyama M, Sugimachi K. Laparoscopy-assisted Billroth I gastrectomy. Surg Laparosc Endosc. 1994;4(2):146-8. Erratum in: Surg Laparosc Endosc. 2013;23(5):480. Kitano S, Iso Y, Moriyama M, Sugimachi K. Laparoscopy-assisted Billroth I gastrectomy. Surg Laparosc Endosc. 1994;4(2):146-8. Erratum in: Surg Laparosc Endosc. 2013;23(5):480.
7.
Zurück zum Zitat Hashizume M, Sugimachi K. Robot-assisted gastric surgery. Surg Clin North Am. 2003;83(6):1429–44.CrossRef Hashizume M, Sugimachi K. Robot-assisted gastric surgery. Surg Clin North Am. 2003;83(6):1429–44.CrossRef
8.
Zurück zum Zitat Uyama I, Suda K, Nakauchi M, et al. Clinical advantages of robotic gastrectomy for clinical stage I/II gastric cancer: a multi-institutional prospective single-arm study. Gastric Cancer. 2019;22(2):377–85.CrossRef Uyama I, Suda K, Nakauchi M, et al. Clinical advantages of robotic gastrectomy for clinical stage I/II gastric cancer: a multi-institutional prospective single-arm study. Gastric Cancer. 2019;22(2):377–85.CrossRef
9.
Zurück zum Zitat Lu J, Zheng CH, Xu BB, et al. Assessment of robotic versus laparoscopic distal gastrectomy for gastric cancer: a randomized controlled trial. Ann Surg. 2021;273(5):858–67.CrossRef Lu J, Zheng CH, Xu BB, et al. Assessment of robotic versus laparoscopic distal gastrectomy for gastric cancer: a randomized controlled trial. Ann Surg. 2021;273(5):858–67.CrossRef
10.
Zurück zum Zitat Kim HI, Han SU, Yang HK, et al. Multicenter prospective comparative study of robotic versus laparoscopic gastrectomy for gastric adenocarcinoma. Ann Surg. 2016;263(1):103–9.CrossRef Kim HI, Han SU, Yang HK, et al. Multicenter prospective comparative study of robotic versus laparoscopic gastrectomy for gastric adenocarcinoma. Ann Surg. 2016;263(1):103–9.CrossRef
11.
Zurück zum Zitat Guerrini GP, Esposito G, Magistri P, et al. Robotic versus laparoscopic gastrectomy for gastric cancer: the largest meta-analysis. Int J Surg. 2020;82:210–28.CrossRef Guerrini GP, Esposito G, Magistri P, et al. Robotic versus laparoscopic gastrectomy for gastric cancer: the largest meta-analysis. Int J Surg. 2020;82:210–28.CrossRef
12.
Zurück zum Zitat Song J, Oh SJ, Kang WH, Hyung WJ, Choi SH, Noh SH. Robot-assisted gastrectomy with lymph node dissection for gastric cancer: lessons learned from an initial 100 consecutive procedures. Ann Surg. 2009;249(6):927–32.CrossRef Song J, Oh SJ, Kang WH, Hyung WJ, Choi SH, Noh SH. Robot-assisted gastrectomy with lymph node dissection for gastric cancer: lessons learned from an initial 100 consecutive procedures. Ann Surg. 2009;249(6):927–32.CrossRef
13.
Zurück zum Zitat Shibasaki S, Suda K, Obama K, Yoshida M, Uyama I. Should robotic gastrectomy become a standard surgical treatment option for gastric cancer? Surg Today. 2020;50(9):955–65.CrossRef Shibasaki S, Suda K, Obama K, Yoshida M, Uyama I. Should robotic gastrectomy become a standard surgical treatment option for gastric cancer? Surg Today. 2020;50(9):955–65.CrossRef
14.
Zurück zum Zitat Park JM, Kim HI, Han SU, et al. Who may benefit from robotic gastrectomy? A subgroup analysis of multicenter prospective comparative study data on robotic versus laparoscopic gastrectomy. Eur J Surg Oncol. 2016;42(12):1944–9.CrossRef Park JM, Kim HI, Han SU, et al. Who may benefit from robotic gastrectomy? A subgroup analysis of multicenter prospective comparative study data on robotic versus laparoscopic gastrectomy. Eur J Surg Oncol. 2016;42(12):1944–9.CrossRef
15.
Zurück zum Zitat Suda K, Man-I M, Ishida Y, Kawamura Y, Satoh S, Uyama I. Potential advantages of robotic radical gastrectomy for gastric adenocarcinoma in comparison with conventional laparoscopic approach: a single institutional retrospective comparative cohort study. Surg Endosc. 2015;29(3):673–85.CrossRef Suda K, Man-I M, Ishida Y, Kawamura Y, Satoh S, Uyama I. Potential advantages of robotic radical gastrectomy for gastric adenocarcinoma in comparison with conventional laparoscopic approach: a single institutional retrospective comparative cohort study. Surg Endosc. 2015;29(3):673–85.CrossRef
16.
Zurück zum Zitat Kim JW. After propensity score matching in long-term oncologic outcomes of robotic gastrectomy for gastric cancer compared with laparoscopic gastrectomy. Gastric Cancer. 2018;21(6):1071.CrossRef Kim JW. After propensity score matching in long-term oncologic outcomes of robotic gastrectomy for gastric cancer compared with laparoscopic gastrectomy. Gastric Cancer. 2018;21(6):1071.CrossRef
17.
Zurück zum Zitat Tian Y, Cao S, Kong Y, et al. Short- and long-term comparison of robotic and laparoscopic gastrectomy for gastric cancer by the same surgical team: a propensity score matching analysis. Surg Endosc. 2021:1-11. Tian Y, Cao S, Kong Y, et al. Short- and long-term comparison of robotic and laparoscopic gastrectomy for gastric cancer by the same surgical team: a propensity score matching analysis. Surg Endosc. 2021:1-11.
18.
Zurück zum Zitat Liao G, Zhao Z, Khan M, Yuan Y, Li X. Comparative analysis of robotic gastrectomy and laparoscopic gastrectomy for gastric cancer in terms of their long-term oncological outcomes: a meta-analysis of 3410 gastric cancer patients. World J Surg Oncol. 2019;17(1):86.CrossRef Liao G, Zhao Z, Khan M, Yuan Y, Li X. Comparative analysis of robotic gastrectomy and laparoscopic gastrectomy for gastric cancer in terms of their long-term oncological outcomes: a meta-analysis of 3410 gastric cancer patients. World J Surg Oncol. 2019;17(1):86.CrossRef
19.
Zurück zum Zitat Obama K, Kim YM, Kang DR, et al. Long-term oncologic outcomes of robotic gastrectomy for gastric cancer compared with laparoscopic gastrectomy. Gastric Cancer. 2018;21(2):285–95.CrossRef Obama K, Kim YM, Kang DR, et al. Long-term oncologic outcomes of robotic gastrectomy for gastric cancer compared with laparoscopic gastrectomy. Gastric Cancer. 2018;21(2):285–95.CrossRef
20.
Zurück zum Zitat Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma, 3rd English edn. Gastric Cancer. 2011;14:101-12. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma, 3rd English edn. Gastric Cancer. 2011;14:101-12.
21.
Zurück zum Zitat Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2018, 5th edn. Gastric Cancer. 2021;24:1-21. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2018, 5th edn. Gastric Cancer. 2021;24:1-21.
22.
Zurück zum Zitat Kamikawa Y, Kobayashi T, Kamiyama S, et al. A new procedure of esophagogastrostomy to prevent reflux following proximal gastrectomy (in Japanese). Shoukakigeka. 2001;24:1053–60. Kamikawa Y, Kobayashi T, Kamiyama S, et al. A new procedure of esophagogastrostomy to prevent reflux following proximal gastrectomy (in Japanese). Shoukakigeka. 2001;24:1053–60.
23.
Zurück zum Zitat Mine S, Nunobe S, Watanabe M. A novel technique of anti-reflux esophagogastrostomy following left thoracoabdominal esophagectomy for carcinoma of the esophagogastric junction. World J Surg. 2015;39(9):2359–61.CrossRef Mine S, Nunobe S, Watanabe M. A novel technique of anti-reflux esophagogastrostomy following left thoracoabdominal esophagectomy for carcinoma of the esophagogastric junction. World J Surg. 2015;39(9):2359–61.CrossRef
24.
Zurück zum Zitat Yamashita Y, Yamamoto A, Tamamori Y, Yoshii M, Nishiguchi Y. Side overlap esophagogastrostomy to prevent reflux after proximal gastrectomy. Gastric Cancer. 2017;20(4):728–35.CrossRef Yamashita Y, Yamamoto A, Tamamori Y, Yoshii M, Nishiguchi Y. Side overlap esophagogastrostomy to prevent reflux after proximal gastrectomy. Gastric Cancer. 2017;20(4):728–35.CrossRef
26.
Zurück zum Zitat Gómez Ruiz M, Lainez Escribano M, Cagigas Fernández C, Cristobal Poch L, Santarrufina Martínez S. Robotic surgery for colorectal cancer. Ann Gastroenterol Surg. 2020;4(6):646–51.CrossRef Gómez Ruiz M, Lainez Escribano M, Cagigas Fernández C, Cristobal Poch L, Santarrufina Martínez S. Robotic surgery for colorectal cancer. Ann Gastroenterol Surg. 2020;4(6):646–51.CrossRef
27.
Zurück zum Zitat Leal Ghezzi T, Campos Corleta O. 30 years of robotic surgery. World J Surg. 2016;40(10):2550–7.CrossRef Leal Ghezzi T, Campos Corleta O. 30 years of robotic surgery. World J Surg. 2016;40(10):2550–7.CrossRef
28.
Zurück zum Zitat Yu J, Huang C, Sun Y, et al. Chinese Laparoscopic Gastrointestinal Surgery Study (CLASS) Group Effect of laparoscopic vs open distal gastrectomy on 3-year disease-free survival in patients with locally advanced gastric cancer: the CLASS-01 randomized clinical trial. JAMA. 2019;321(20):1983-92. Yu J, Huang C, Sun Y, et al. Chinese Laparoscopic Gastrointestinal Surgery Study (CLASS) Group Effect of laparoscopic vs open distal gastrectomy on 3-year disease-free survival in patients with locally advanced gastric cancer: the CLASS-01 randomized clinical trial. JAMA. 2019;321(20):1983-92.
29.
Zurück zum Zitat Ojima T, Nakamura M, Nakamori M, et al. Robotic versus laparoscopic gastrectomy with lymph node dissection for gastric cancer: study protocol for a randomized controlled trial. Trials. 2018;19(1):409.CrossRef Ojima T, Nakamura M, Nakamori M, et al. Robotic versus laparoscopic gastrectomy with lymph node dissection for gastric cancer: study protocol for a randomized controlled trial. Trials. 2018;19(1):409.CrossRef
30.
Zurück zum Zitat Cui H, Cao B, Liu G, et al. Comparison of short-term outcomes and quality of life in totally laparoscopic distal gastrectomy and totally robotic distal gastrectomy for clinical stage I-III gastric cancer: study protocol for a multi-institutional randomised clinical trial. BMJ Open. 2021;11(5):e043535.CrossRef Cui H, Cao B, Liu G, et al. Comparison of short-term outcomes and quality of life in totally laparoscopic distal gastrectomy and totally robotic distal gastrectomy for clinical stage I-III gastric cancer: study protocol for a multi-institutional randomised clinical trial. BMJ Open. 2021;11(5):e043535.CrossRef
Metadaten
Titel
Propensity Score-Matched Analysis of the Short- and Long-Term Outcomes of Robotic Versus Laparoscopic Gastrectomy for Gastric Cancer
verfasst von
Masaaki Nishi, MD, PhD, FACS
Mistuo Shimada, MD
Kozo Yoshikawa, MD
Chie Takasu, MD
Yuma Wada, MD
Takuya Tokunaga, MD
Toshihiro Nakao, MD
Hideya Kashihara, MD
Toshiaki Yoshimoto, MD
Shoko Yamashita, MD
Publikationsdatum
10.01.2022
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 6/2022
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-021-11203-7

Neu im Fachgebiet Chirurgie

US-Team empfiehlt Gastropexie nach Hiatushernien-Op.

Zur Vermeidung von Rezidiven nach Reparatur einer paraösophagealen Hiatushernie sollte einem US-Team zufolge der Magen bei der Op. routinemäßig an der Bauchwand fixiert werden. Das Ergebnis einer randomisierten Studie scheint dafür zu sprechen.

Mit Lidocain kommt der Darm nicht schneller in Schwung

Verzögertes Wiederanspringen der Darmfunktion ist ein Hauptfaktor dafür, wenn Patientinnen und Patienten nach einer Kolonresektion länger als geplant im Krankenhaus bleiben müssen. Ob man diesem Problem mit Lidocain vorbeugen kann, war Thema einer Studie.

Kein Unterschied bei inadäquaten Schocks zwischen ICD-Typen

Inadäquate Schockabgaben sind ein unerwünschter Effekt der Therapie mit implantierbaren Kardioverter-Defibrillatoren. Subkutanen Geräten haftet dabei der Ruf an, dafür besonders anfällig zu sein. Die PRAETORIAN-Forschungsgruppe ist dem nachgegangen.

DCIS: Ist ein Verzicht auf eine Operation möglich?

Die COMET-Studie zeigt, dass aktives Monitoring bei Patientinnen mit duktalem Carcinoma in situ (DCIS) hinsichtlich der kumulativen Zwei-Jahres-Rate an ipsilateralen invasiven Karzinomen der leitliniengerechten Standardbehandlung nicht unterlegen ist. Dennoch wird von einem Verzicht auf eine Operation abgeraten, wie in einem begleitenden Editorial betont wird.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.